These are exciting times, with fresh news about research developments appearing every week.
Find out about the latest research news below and also visit our Breaking News in Research page.
The second phase of an LGMD 2B study is looking for participantsRead more
The European Medicines Agency (EMA) has granted Orphan Drug Designation to Resolaris (ATYR1940) for the treatment of all types of limb girdle muscular dystrophy (LGMD).
Researchers at the University of Edinburgh have discovered that nuclear membrane proteins play a role in the development of the muscles in the body.
We are pleased to announce that a Muscular Dystrophy UK funded study examining the effect of Duchenne muscular dystrophy on the brain is now open for recruitment.
New research suggest that muscle development is affected even before birth in this group of conditions.
These could help to monitor the progression of the conditions as well as measure the response to treatment.
Read the lay report of the latest ENMC workshop
Early in October the annual international conference of the World Muscle Society brought together more than 500 scientists and clinicians from all over the world to discuss the lat
We are delighted to announce funding of over £1,000,000 for neuromuscular research over the next four years.
An online questionnaire study examining how psychological factors impact on quality of life and mood over time has been started by Researchers based at Edinburgh University.
The team at the MRC Centre for Neuromuscular Diseases in London are recruiting people with a neuromuscular condition where the genetic cause is unknown to take part in the 100K gen